Enzychem Lifesciences Corporation (KOSDAQ:183490)
South Korea
· Delayed Price · Currency is KRW 1,109.00
+28.00 (2.59%)
Apr 1, 2025, 3:30 PM KST
Enzychem Lifesciences Revenue
In the year 2024, Enzychem Lifesciences had annual revenue of 77.38B KRW with 1.76% growth. Enzychem Lifesciences had revenue of 18.52B in the quarter ending December 31, 2024, a decrease of -20.23%.
Revenue
77.38B
Revenue Growth
+1.76%
P/S Ratio
1.14
Revenue / Employee
634.24M
Employees
122
Market Cap
86.30B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,547.32B |
| Celltrion | 3,557.30B |
| ALTEOGEN | 102.85B |
| Yuhan | 2,067.79B |
| SK Biopharmaceuticals | 547.60B |
| HLB Co., Ltd. | 51.92B |
| Sam Chun Dang Pharm. | 210.92B |
| PharmaResearch | 350.12B |